![Clinical Trials - analysis End-points, planned and unplanned secondary analyses, interim analyses, stopping rules Dick Menzies, MD Respiratory Epidemiology. - ppt download Clinical Trials - analysis End-points, planned and unplanned secondary analyses, interim analyses, stopping rules Dick Menzies, MD Respiratory Epidemiology. - ppt download](https://images.slideplayer.com/27/9010897/slides/slide_2.jpg)
Clinical Trials - analysis End-points, planned and unplanned secondary analyses, interim analyses, stopping rules Dick Menzies, MD Respiratory Epidemiology. - ppt download
![The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-33192-1/MediaObjects/41467_2022_33192_Fig1_HTML.png)
The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications
Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease | PLOS Medicine
![Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS | Neurology Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS | Neurology](https://n.neurology.org/sites/default/files/highwire/neurology/100/23.cover-source.jpg)
Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS | Neurology
![Frontiers | Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers Frontiers | Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers](https://www.frontiersin.org/files/Articles/636561/fonc-11-636561-HTML/image_m/fonc-11-636561-g001.jpg)
Frontiers | Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers
![RenovoRx Presenting Phase III Clinical Trial Interim Analysis Data of the TIGeR-PaC Study at American Association for Cancer Research Annual Meeting Underway in Orlando, Florida - RenovoRx RenovoRx Presenting Phase III Clinical Trial Interim Analysis Data of the TIGeR-PaC Study at American Association for Cancer Research Annual Meeting Underway in Orlando, Florida - RenovoRx](https://renovorx.com/wp-content/uploads/2023/04/aacr.jpg)
RenovoRx Presenting Phase III Clinical Trial Interim Analysis Data of the TIGeR-PaC Study at American Association for Cancer Research Annual Meeting Underway in Orlando, Florida - RenovoRx
![Sample size reassessment. Notes: If the first interim analysis shows... | Download Scientific Diagram Sample size reassessment. Notes: If the first interim analysis shows... | Download Scientific Diagram](https://www.researchgate.net/publication/323963544/figure/fig2/AS:607334791393285@1521811306979/Sample-size-reassessment-Notes-If-the-first-interim-analysis-shows-worse-results-than.png)
Sample size reassessment. Notes: If the first interim analysis shows... | Download Scientific Diagram
![Seamless trials. Notes: After first interim analysis, the high-dose arm... | Download Scientific Diagram Seamless trials. Notes: After first interim analysis, the high-dose arm... | Download Scientific Diagram](https://www.researchgate.net/publication/323963544/figure/fig3/AS:607334795587585@1521811307025/Seamless-trials-Notes-After-first-interim-analysis-the-high-dose-arm-showing-serious.png)